FMC · Fmc Corp
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $153M | second quarter 2026 | — |
|
|
|||
| Free cash flow non-GAAP | $357M | second quarter 2026 | — |
| Like-for-Like Revenue Change (Non-GAAP) non-GAAP | -15% | Q2 2026 | — |
| Total Revenue Change (ex-India) (Non-GAAP) non-GAAP | -20% | Q2 2026 | — |
| Adjusted Earnings per diluted share non-GAAP | $2.96 | Full Year 2025 | — |
| EBITDA margin non-GAAP | 26% | Q4 2025 | — |
| Fourth quarter 2025 revenue excluding India non-GAAP | 1.09B | Q4 2025 | — |
| Sales of new active ingredients | $200M | Full Year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Agricultural Inputs — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FMC
this stock
Fmc Corp
|
$1.27B | -26.8% | +69.3% | — | 21.3% |
|
CTVA
Corteva, Inc.
|
$51.16B | +14.4% | +2.9% | 50.1 | 2.7% |
|
NTR
Nutrien Ltd.
|
$32.56B | +10.6% | — | — | 0.8% |
|
CF
CF Industries Holdings, Inc.
|
$17.90B | +53.0% | +19.3% | 8.8 | 5.3% |
|
YARIY
Yara International ASA
|
$11.30B | +8.8% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FMC | -4.2% | -9.5% | -25.7% | -5.2% | -26.8% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -4.6% | -13.9% | -39.5% | -9.2% | -40.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.